Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

AVANTOR, INC.

(AVTR)
  Report
Delayed Nyse  -  04:00 2022-09-30 pm EDT
19.60 USD   -2.97%
09/29Avantor® to Host Third Quarter 2022 Earnings Call on Friday, October 28, 2022
PR
09/19Stifel Adjusts Avantor's Price Target to $28 From $35, Reiterates Buy Rating
MT
09/15North American Morning Briefing: More Muted Gains -2-
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Avantor : reg; Announces Offering of Senior Notes - Form 8-K

10/20/2021 | 05:14pm EDT

Avantor® Announces Offering of Senior Notes

RADNOR, Pa., Oct. 19, 2021 -Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today the commencement of a private offering of senior notes (the "Notes") to be issued by its wholly-owned subsidiary, Avantor Funding, Inc. (the "Issuer"). The Notes will be guaranteed on a joint and several basis by Vail Holdco Sub LLC, the Issuer's direct parent and a direct wholly-owned subsidiary of Avantor ("Holdco"), and by each of Holdco's wholly-owned domestic subsidiaries that guarantees obligations under the Issuer's senior secured credit facilities.

The Issuer intends to use the net proceeds from the sale of the Notes, along with the net proceeds from certain other financing transactions, cash on hand and borrowings under Avantor's A/R facility, to finance Avantor's previously announced acquisition of the Masterflex bioprocessing business and related assets of Antylia Scientific and to pay related fees and expenses.

The offering of the Notes will be made in a private transaction in reliance upon an exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), in the United States only to persons reasonably believed to be "qualified institutional buyers," as that term is defined in Rule 144A under the Securities Act, or outside the United States pursuant to Regulation S under the Securities Act. The Notes have not been registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States without registration or an applicable exemption from registration requirements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of any of the Notes in any jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About Avantor

Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.

Forward-Looking and Cautionary Statements

This press release contains forward-looking statements. All statements other than statements of historical fact included in this press release are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our announced transaction with Masterflex and the related financing, as well as our financial condition, results of operations, plans, objectives, future performance and business. These statements may be preceded by, followed by or include the words "aim," "anticipate," "believe," "estimate," "expect," "forecast," "intend," "likely," "outlook," "plan," "potential," "project," "projection," "seek," "can," "could," "may," "should," "would," "will," the negatives thereof and other words and terms of similar meaning.

Forward-looking statements are inherently subject to risks, uncertainties and assumptions; they are not guarantees of performance. You should not place undue reliance on these statements. We have based these forward-looking statements on our current expectations and projections about future events. Although we believe that our assumptions made in connection with the forward-looking statements are reasonable, we cannot assure you that the assumptions and expectations will prove to be correct. Factors that could contribute to these risks, uncertainties and assumptions include, but are not limited to, our current expectations and assumptions regarding capital market conditions, our ability to successfully integrate Masterflex into our operations and achieve anticipated synergies and our ability to execute related financing on favorable terms, as well as the factors described in "Risk Factors" in our 2020 Annual Report on Form 10-K for the year ended December 31, 2020, and in any subsequent Quarterly Reports on Form 10-Q.

All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing cautionary statements. In addition, all forward-looking statements speak only as of the date of this press release. We undertake no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise other than as required under the federal securities laws.

Media Contact

Allison Hosak

Senior Vice President, Global Communications and Brand

Avantor

908-329-7281

Allison.Hosak@Avantorsciences.com

Investor Relations Contact

Tommy J. Thomas, CPA

Vice President, Investor Relations

Page | 2

Avantor

781-375-8051

Tommy.Thomas@Avantorsciences.com

SOURCE Avantor and Financial News

###

Page | 3

Disclaimer

Avantor Inc. published this content on 20 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 October 2021 21:13:06 UTC.


© Publicnow 2021
All news about AVANTOR, INC.
09/29Avantor® to Host Third Quarter 2022 Earnings Call on Friday, October 28, 2022
PR
09/19Stifel Adjusts Avantor's Price Target to $28 From $35, Reiterates Buy Rating
MT
09/15North American Morning Briefing: More Muted Gains -2-
DJ
09/15KeyBanc Adjusts Avantor's Price Target to $40 From $51, Reiterates Overweight Rating
MT
09/14UBS Adjusts Avantor Price Target to $42 From $45, Maintains Buy Rating
MT
09/14Citigroup Adjusts Avantor's Price Target to $28 From $32, Maintains Neutral Rating
MT
09/14Cowen Downgrades Avantor to Market Perform From Outperform, Adjusts Price Target to $28..
MT
09/13Avantor Sees Up to $1.85 Billion in Q3 Net Sales
MT
09/13Avantor, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
09/12Transcript : Avantor, Inc. Presents at Morgan Stanley 20th Annual Global Heal..
CI
More news
Analyst Recommendations on AVANTOR, INC.
More recommendations
Financials (USD)
Sales 2022 7 715 M - -
Net income 2022 712 M - -
Net Debt 2022 5 686 M - -
P/E ratio 2022 18,3x
Yield 2022 0,18%
Capitalization 13 211 M 13 211 M -
EV / Sales 2022 2,45x
EV / Sales 2023 2,21x
Nbr of Employees 13 500
Free-Float 96,4%
Chart AVANTOR, INC.
Duration : Period :
Avantor, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AVANTOR, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 19,60 $
Average target price 34,75 $
Spread / Average Target 77,3%
EPS Revisions
Managers and Directors
Michael Stubblefield President, Chief Executive Officer & Director
Thomas A. Szlosek Chief Financial Officer & Executive Vice President
Jonathan M. Peacock Chairman
Michael Wondrasch Chief Information Officer & Executive VP
Sheri Lewis Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
AVANTOR, INC.-53.49%13 211
ABBOTT LABORATORIES-31.25%169 448
MEDTRONIC PLC-21.94%107 329
BECTON, DICKINSON AND COMPANY-9.33%63 550
HOYA CORPORATION-18.88%34 437
DEXCOM, INC.-40.00%31 619